Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|May 11, 2010
The PEA-15 protein regulates autophagy via activation of JNKBarbara C Böck, Katrin E Tagscherer, Anne Fassl, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 12, 2008
BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosisGeorg Gdynia, Judith Lehmann-Koch, Sebastian Sieber, et al.
Pathologie (Heidelberg, Germany)|March 6, 2024
[Fluorescence confocal microscopy-complete digitization of pathology]Andreas G Loth, Anne Fassl, Felix K H Chun, et al.
Cancer Research|October 21, 2010
Danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondriaGeorg Gdynia, Martina Keith, Jürgen Kopitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exitTobias Otto, Sheyla V Candido, Mary S Pilarz, et al.
BJU International|July 10, 2024
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancerMike Wenzel, Benedikt Hoeh, Florestan Koll, et al.
Nature Communications|September 11, 2021
Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancerFabin Dang, Li Nie, Jin Zhou, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate CancerFu Gui, Baishan Jiang, Jie Jiang, et al.
Science Advances|April 23, 2025
Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancerFu Gui, Baishan Jiang, Jie Jiang, et al.
Pageof 4